Work

Sp121a Phase 2/3 Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome

Year: 2018

Type: article

Source: Nephrology Dialysis Transplantation

DOI: 10.1093/ndt/gfy104.sp121

Authors: Oliver Gross, Gerald Appel, Geoffrey Block, Melanie Chin, Angie Goldsberry, Lesley Inker, Colin Meyer, Pablo Pergola, James Simon, Bradley Warady, Phillip Zaoui, Michelle Rheault, Clifford Kashtan

Institutions: Universitätsmedizin Göttingen, University of Göttingen, Columbia University Irving Medical Center, Colorado Kidney Care, Reata Pharmaceuticals (United States), Tufts Medical Center, Renal Associates P. A., Cleveland Clinic, Children's Mercy Hospital, Centre Hospitalier Universitaire de Grenoble, University of Minnesota

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4252966407

FWCI: 1.031

Cites:

Cited by: 5

Related to: 10